Journal of Cancer Research and Therapeutics Close
 

Figure 2: Pathology of UNDS: (a and b) Hematoxylin and eosin-stained sections an intermediate (×400). (c-e) Representative high-magnification images (×400) of immunohistochemical staining for Vimentin+ (c), CD99− (d), and Ki67+/− (e)

Figure 2: Pathology of UNDS: (a and b) Hematoxylin and eosin-stained sections an intermediate (×400). (c-e) Representative high-magnification images (×400) of immunohistochemical staining for Vimentin+ (c), CD99− (d), and Ki67+/− (e)